15632381

Source:http://linkedlifedata.com/resource/pubmed/id/15632381

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0009566, umls-concept:C0242379, umls-concept:C0243127, umls-concept:C0262950, umls-concept:C0280100, umls-concept:C0376358, umls-concept:C0443331, umls-concept:C0521324, umls-concept:C0684249, umls-concept:C2698872, umls-concept:C2745888
pubmed:issue	1
pubmed:dateCreated	2005-1-5
pubmed:abstractText	Whether bone markers have prognostic value in patients with bone metastases is unknown. We investigated this question in patients with bone metastases secondary to prostate cancer and to non-small-cell lung cancer (NSCLC) and other solid tumors assigned to the placebo arms of two phase III trials of zoledronic acid.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7503089
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Alkaline Phosphatase, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Collagen, http://linkedlifedata.com/resource/pubmed/chemical/Collagen Type I, http://linkedlifedata.com/resource/pubmed/chemical/Diphosphonates, http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles, http://linkedlifedata.com/resource/pubmed/chemical/Peptides, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological, http://linkedlifedata.com/resource/pubmed/chemical/collagen type I trimeric..., http://linkedlifedata.com/resource/pubmed/chemical/zoledronic acid
pubmed:status	MEDLINE
pubmed:month	Jan
pubmed:issn	1460-2105
pubmed:author	pubmed-author:BrownJanet EJE, pubmed-author:ColemanRobert ERE, pubmed-author:CookRichard JRJ, pubmed-author:HeiYong-JiangYJ, pubmed-author:LeeKer-AiKA, pubmed-author:LiptonAllanA, pubmed-author:MajorPierreP, pubmed-author:SaadFredF, pubmed-author:SmithMatthewM, pubmed-author:ZhengMingM
pubmed:issnType	Electronic
pubmed:day	5
pubmed:volume	97
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	59-69
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:15632381-Adult, pubmed-meshheading:15632381-Aged, pubmed-meshheading:15632381-Alkaline Phosphatase, pubmed-meshheading:15632381-Antineoplastic Agents, pubmed-meshheading:15632381-Bone Neoplasms, pubmed-meshheading:15632381-Bone Regeneration, pubmed-meshheading:15632381-Carcinoma, Non-Small-Cell Lung, pubmed-meshheading:15632381-Clinical Trials, Phase III as Topic, pubmed-meshheading:15632381-Cohort Studies, pubmed-meshheading:15632381-Collagen, pubmed-meshheading:15632381-Collagen Type I, pubmed-meshheading:15632381-Diphosphonates, pubmed-meshheading:15632381-Double-Blind Method, pubmed-meshheading:15632381-Female, pubmed-meshheading:15632381-Humans, pubmed-meshheading:15632381-Imidazoles, pubmed-meshheading:15632381-Lung Neoplasms, pubmed-meshheading:15632381-Male, pubmed-meshheading:15632381-Middle Aged, pubmed-meshheading:15632381-Multicenter Studies as Topic, pubmed-meshheading:15632381-Neoplasms, pubmed-meshheading:15632381-Peptides, pubmed-meshheading:15632381-Predictive Value of Tests, pubmed-meshheading:15632381-Prognosis, pubmed-meshheading:15632381-Proportional Hazards Models, pubmed-meshheading:15632381-Prostatic Neoplasms, pubmed-meshheading:15632381-Risk Assessment, pubmed-meshheading:15632381-Risk Factors, pubmed-meshheading:15632381-Time Factors, pubmed-meshheading:15632381-Tumor Markers, Biological
pubmed:year	2005
pubmed:articleTitle	Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors.
pubmed:affiliation	Academic Unit of Clinical Oncology, Cancer Research Centre, Weston Park Hospital, Sheffield, England, United Kingdom.
pubmed:publicationType	Journal Article